New diabetes clinical trial: A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin.

Published on: October 01, 2023 at 11:00PM
Conditions: Hypertension; Diabetes Mellitus, Type 2
Interventions: Drug: THP-00101 (Dapagliflozin) 10mg; Drug: THP-00102 (Telmisartan) 80mg
Sponsors: THPharm Corp.
Recruiting
https://ift.tt/0qECgRr